GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples